Table 2.
Medical and clinical characteristics of participants in the case-control groups.
| Control Group | MASLD | p-Value | ||||
|---|---|---|---|---|---|---|
| N | (%) | N | (%) | |||
| Family history | No | 11 | (18.3) | 11 | (18.3) | 1.00 |
| Yes | 49 | (81.7) | 49 | (81.7) | ||
| Rationale of diagnosis | None | 60 | (100.0) | 13 | (21.7) | 0.000 |
| Routine test | 0 | (0.0) | 0 | (0.0) | ||
| Liver test abnormal | 0 | (0.0) | 37 | (61.7) | ||
| Obesity consultation | 0 | (0.0) | 7 | (11.7) | ||
| Family history of MASLD | 0 | (0.0) | 0 | (0.0) | ||
| Digestive symptoms | 0 | (0.0) | 3 | (5.0) | ||
| Duration of disease | Recently diagnosed | 60 | (100.0) | 1 | (1.7) | 0.000 |
| Less than 1 year | 0 | (0.0) | 29 | (48.3) | ||
| From 1 to 3 year | 0 | (0.0) | 15 | (25.0) | ||
| More than 3 years | 0 | (0.0) | 15 | (25.0) | ||
| Current treatment | No | 51 | (85.0) | 22 | (36.7) | <0.001 |
| Yes | 9 | (15.0) | 38 | (63.7) | ||
| Type of treatments | No treatment | 51 | (85.0) | 22 | (36.7) | <0.001 |
| Liver diseases | 0 | (0.0) | 3 | (5.0) | ||
| Hypertension | 5 | (8.3) | 5 | (8.3) | ||
| Diabetes | 0 | (0.0) | 5 | (8.3) | ||
| Hypercholesterolemia | 2 | (3.3) | 16 | (26.7) | ||
| Liver diseases and hypertension | 2 | (3.3) | 9 | (15.0) | ||
| Past Medical History | No | 53 | (88.3) | 57 | (95.0) | 0.18 |
| Yes | 7 | (11.7) | 3 | (5.0) | ||
| Hypertension | Absent | 48 | (80.0) | 36 | (60.0) | 0.017 |
| Present | 12 | (20.0) | 24 | (40.0) | ||
| Diabetes | Absent | 60 | (100.0) | 42 | (70.0) | 0.000 |
| Present | 0 | (0.0) | 18 | (30.0) | ||
| Other Past Medical History | None | 60 | (100.0) | 58 | (96.7) | 0.15 |
| Respiratory and circulatory diseases | 0 | (0.0) | 2 | (3.3) | ||
| Digestive diseases | 0 | (0.0) | 0 | (0.0) | ||
| Cancer | 0 | (0.0) | 0 | (0.0) | ||